Andere Sprachen Entrada Therapeutics, Inc.

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.05.2024			% 5 Tage	% 1. Jan.
14,99 ^USD	+0,27 %		+4,53 %	-0,66 %

16.05.	Entrada Therapeutics Insider kaufte Aktien im Wert von $364,673, laut einer aktuellen SEC Einreichung	MT
07.05.	Entrada Therapeutics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing	16.05.
Entrada Therapeutics to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ	16.05.
Entrada Therapeutics : Corporate Presentation	07.05.
Entrada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.
Entrada Therapeutics Reports First Quarter 2024 Financial Results	07.05.
Entrada Therapeutics : Corporate Presentation	13.03.
Entrada Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
Entrada Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13.03.
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	13.03.
North American Morning Briefing : Stock Futures -2-	11.03.
Entrada Therapeutics : Corporate Presentation	04.03.
Entrada Therapeutics to Present at Upcoming Investor Conferences	07.02.
Entrada Therapeutics Adds President Role to COO Nathan Dowden	03.01.
Entrada Therapeutics Adds President Role to COO Nathan Dowden	03.01.
Sector Update: Health Care Stocks Gain Pre-Bell Wednesday	03.01.
Entrada Therapeutics Promotes Nathan J. Dowden to President	03.01.
Entrada Therapeutics Promotes Nathan J. Dowden to President	03.01.
Pomerantz Law Firm Investigates Claims On Entrada Therapeutics, Inc. - TRDA	19.12.
Entrada Therapeutics, Inc. cancelled the transaction announced on December 7, 2022	07.12.
Entrada Therapeutics, Inc. Announces Board Changes	06.12.

Keine Ergebnisse zu dieser Suche